We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
+2.91%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$110M
Cap. Flow %
7.96%
Top 10 Hldgs %
26.02%
Holding
618
New
82
Increased
295
Reduced
154
Closed
21

Top Buys

Rank Stock Value
1
OBDE
Blue Owl Capital Corporation III
OBDE
+$8.93M
2
AZN icon
AstraZeneca
AZN
+$4.24M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.9M
4
TEL icon
TE Connectivity
TEL
+$3.61M
5
FSK icon
FS KKR Capital
FSK
+$3.54M

Top Sells

Rank Stock Value
1
OBDC icon
Blue Owl Capital
OBDC
+$10.9M
2
JNJ icon
Johnson & Johnson
JNJ
+$4.45M
3
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$2.17M
4
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$2.14M
5
ZM icon
Zoom
ZM
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Financials 16.04%
3 Healthcare 10.13%
4 Consumer Discretionary 4.67%
5 Communication Services 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
26
Home Depot
HD
$332B
$10.1M 0.73%
29,235
+1,429
+5% +$487K
AVGO icon
27
Broadcom
AVGO
$1.82T
$10M 0.73%
62,560
-1,840
-3% -$258K
VTV icon
28
Vanguard Value ETF
VTV
$189B
$9.86M 0.72%
61,484
-439
-0.7% -$70.2K
V icon
29
Visa
V
$677B
$9.63M 0.7%
36,671
+7,873
+27% +$2.16M
OBDE
30
DELISTED
Blue Owl Capital Corporation III
OBDE
$8.65M 0.63%
+577,763
New +$8.93M
XLV icon
31
State Street Health Care Select Sector SPDR ETF
XLV
$42B
$8.45M 0.61%
57,981
-14,949
-20% -$2.14M
TCPC icon
32
BlackRock TCP Capital
TCPC
$265M
$8.43M 0.61%
780,960
+297,393
+61% +$3.15M
VV icon
33
Vanguard Large-Cap ETF
VV
$51.9B
$8.42M 0.61%
33,727
+2
+0% +$480
BMY icon
34
Bristol-Myers Squibb
BMY
$127B
$8.35M 0.61%
201,080
+4,354
+2% +$195K
ABBV icon
35
AbbVie
ABBV
$458B
$7.93M 0.58%
46,227
+17,559
+61% +$2.91M
BX icon
36
Blackstone
BX
$104B
$7.83M 0.57%
63,248
+3,336
+6% +$411K
NOBL icon
37
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
$7.67M 0.56%
159,492
+13,484
+9% +$660K
VTI icon
38
Vanguard Total Stock Market ETF
VTI
$654B
$7.09M 0.51%
26,516
-117
-0.4% -$30.3K
SPYG icon
39
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.7B
$6.94M 0.5%
86,551
+4,174
+5% +$312K
JMBS icon
40
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.71B
$6.85M 0.5%
153,400
-2,052
-1% -$91K
VEU icon
41
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$6.79M 0.49%
115,706
-3,532
-3% -$207K
IEFA icon
42
iShares Core MSCI EAFE ETF
IEFA
$186B
$6.76M 0.49%
93,100
-811
-0.9% -$59.7K
RSP icon
43
Invesco S&P 500 Equal Weight ETF
RSP
$96.3B
$6.62M 0.48%
40,326
+6,814
+20% +$1.12M
IBTF
44
DELISTED
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
$6.35M 0.46%
273,265
+111,915
+69% +$2.59M
TLH icon
45
iShares 10-20 Year Treasury Bond ETF
TLH
$11B
$6.26M 0.45%
60,939
+503
+0.8% +$51.2K
ADP icon
46
Automatic Data Processing
ADP
$100B
$6.22M 0.45%
26,071
+791
+3% +$194K
IBTI icon
47
iShares iBonds Dec 2028 Term Treasury ETF
IBTI
$1.86B
$6.1M 0.44%
279,598
+89,673
+47% +$1.95M
AZN icon
48
AstraZeneca
AZN
$263B
$6.08M 0.44%
38,956
+28,198
+262% +$4.24M
CVX icon
49
Chevron
CVX
$388B
$5.73M 0.42%
36,657
+450
+1% +$71.8K
MDT icon
50
Medtronic
MDT
$107B
$5.66M 0.41%
71,929
+2,219
+3% +$182K
1
2
3 4 5

Similar funds

GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.25B AUM 12.03% 1-Year Est. Return
LIA
Limestone Investment Advisors New York $1.25B AUM 25.43% 1-Year Est. Return
LMGAM
Liberty Mutual Group Asset Management Boston, Massachusetts $1.25B AUM 45.27% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return
FFM
Fullerton Fund Management Singapore $1.25B AUM 76.88% 1-Year Est. Return
TCA
Teewinot Capital Advisers New York $1.25B AUM 32.55% 1-Year Est. Return
DP
Dundas Partners Edinburgh, United Kingdom $1.25B AUM 13.92% 1-Year Est. Return

Transcend Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Transcend Capital Advisors held 618 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Transcend Capital Advisors deployed $110M of net new capital in Q2 2024, opening 82 new positions and adding to 295 existing holdings. Its largest new stake was Blue Owl Capital Corporation III: 577,763 shares worth $8.65M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Blue Owl Capital, an estimated $10.9M trimmed.

  • Transcend Capital Advisors's largest Q2 2024 buy was Blue Owl Capital Corporation III: 577,763 shares worth $8.65M.
  • Transcend Capital Advisors added most to AstraZeneca in Q2 2024, an estimated $4.24M increase.
  • Transcend Capital Advisors's biggest Q2 2024 reduction was Blue Owl Capital, cutting an estimated $10.9M.
  • Transcend Capital Advisors fully exited Crane Co in Q2 2024, selling an estimated $480K.
  • Transcend Capital Advisors's ten largest holdings make up 26% of its $1.38B portfolio in Q2 2024.
  • Transcend Capital Advisors opened 82 new positions and closed 21 in Q2 2024.
  • Transcend Capital Advisors's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Transcend Capital Advisors's 13F filing for Q2 2024, filed 2 Jul 2024.